货号：UP639794104
| 产品信息 | |
| 产品名称： | MK-8245 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1030612-90-8 |
| 分子式： | C17H16BrFN6O4 |
| 分子量： | 467.25 |
| MDL NO： | MFCD20039622 |
| 标准纯度： | 98+% (UP639794104) |
| 沸点： | - |
| 储存： | (UP639794104) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
2-Isopropylfuran
UP22389030510599-59-4
Masoprocol
UP43304455227686-84-6
4-Methoxybenzo[d]isoxazole
UP5620299041360943-30-1
SB-239063
UP280765304193551-21-2
SB-242235
UP198836187193746-75-7
Skepinone-L
UP9428756681221485-83-1
SB-202190
UP588630853152121-30-7
2,4-Dimethyl-1,2,3,4-tetrahydroquinoline
UP61518680319343-79-4
Sunitinib Malate
UP307944573341031-54-7
Doramapimod
UP992829021285983-48-4
Ciliobrevin A
UP907738183302803-72-1
CX-6258 Hydrochloride
UP3474349601353859-00-3
BIX-01294 Trihydrochloride
UP7237782531392399-03-9
(3-Ethoxy-3-oxopropyl)triphenylphosphonium bromide
UP31510195742843-94-7
GSK650394
UP459725045890842-28-1
6-Fluoro-1,2,3,4-tetrahydroquinoline
UP68777220759611-52-8
MS023
UP1545284221831110-54-3
SGC707
UP3544594881687736-54-4
Acumapimod
UP760151434836683-15-9
ISCK03
UP860733986945526-43-2
2-PMPA
UP900217398173039-10-6
7-Bromo-1,2,3,4-tetrahydroquinoline
UP267073928114744-51-3
8-Bromotetrazolo[1,5-a]pyridine
UP97439398254230-88-5
SKF-86002
UP56706844972873-74-6
Masitinib mesylate
UP1204457681048007-93-7
2,7-Dibromo-9,9-dimethyl-9,10-dihydroacridine
UP9819195911333316-35-0
LLY-507
UP7486531571793053-37-8
3,3-Dimethylindoline
UP2037143141914-02-9
2-Bromo-4-methyl-1H-imidazole
UP59662552823328-88-3
Lesinurad sodium
UP2473452011151516-14-1
Ethyl N-(mesitylsulfonyl)oxyacetimidate
UP94154419538202-27-6
Pamapimod
UP895184163449811-01-2
Motesanib
UP499561434453562-69-1
Di-tert-butyl iminodicarboxylate
UP23514888051779-32-9
6-Fluoro-2-methyl-1,2,3,4-tetrahydroquinoline
UP55715251042835-89-2
CX-6258 hydrochloride hydrate
UP7334379691353858-99-7
UNC0638
UP2072128601255580-76-7
BIX-01294
UP122937197935693-62-2
SAG HCl
UP8267666952095432-58-7
Perchloropyridazine
UP49021237020074-67-3
Sorafenib tosylate
UP644091340475207-59-1
WEHI-539
UP2827677521431866-33-9
9,9-Dimethyl-9,10-dihydroacridine
UP5392896526267-02-3
Bismuth Subsalicylate
UP32437481014882-18-9
HA14-1
UP57681675665673-63-4
MK-8245
UP6397941041030612-90-8